Search research articles
Contact Us
Filters
Showing results (71-80 of 133) with videos related to
Page
of 14
Sort By:
La Revue De Medecine Interne
|
January 29, 2019
[CAR-T cells: Lymphocytes that express a chimeric antigen receptor]
C Chabannon, R Bouabdallah, S Fürst, et al.
Bone Marrow Transplantation
|
June 4, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation
|
August 1, 1997
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer
P Viens, G Gravis, D Genre, et al.
Bone Marrow Transplantation
|
February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT
R Devillier, R Crocchiolo, L Castagna, et al.
Revue D'Epidemiologie Et De Sante Publique
|
April 1, 1996
[Comparative study of the costs for two hematopoietic cell specimen collections: cytapheresis and bone marrow collection]
A G Le Corroller, G Macquart-Moulin, P Auquier, et al.
Bone Marrow Transplantation
|
March 3, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation
|
March 6, 2007
CD34(+) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation
C Lemarie, B Esterni, B Calmels, et al.
Cytotherapy
|
June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMT
M Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation
|
February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
H de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation
|
August 26, 1998
Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation
C Faucher, C Fortanier, P Viens, et al.
Page
of 14
Search research articles
Search
Showing results (71-80 of 133) with videos related to
Sort By:
Page
of 14
La Revue De Medecine Interne
|
January 29, 2019
[CAR-T cells: Lymphocytes that express a chimeric antigen receptor]
C Chabannon, R Bouabdallah, S Fürst, et al.
Bone Marrow Transplantation
|
June 4, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation
|
August 1, 1997
High-dose sequential chemotherapy with stem cell support for non-metastatic breast cancer
P Viens, G Gravis, D Genre, et al.
Bone Marrow Transplantation
|
February 7, 2012
The increase from 2.5 to 5 mg/kg of rabbit anti-thymocyte-globulin dose in reduced intensity conditioning reduces acute and chronic GVHD for patients with myeloid malignancies undergoing allo-SCT
R Devillier, R Crocchiolo, L Castagna, et al.
Revue D'Epidemiologie Et De Sante Publique
|
April 1, 1996
[Comparative study of the costs for two hematopoietic cell specimen collections: cytapheresis and bone marrow collection]
A G Le Corroller, G Macquart-Moulin, P Auquier, et al.
Bone Marrow Transplantation
|
March 3, 2015
Familial haploidentical challenging unrelated donor Allo-SCT in advanced non-Hodgkin lymphomas when matched related donor is not available
S Garciaz, L Castagna, R Bouabdallah, et al.
Bone Marrow Transplantation
|
March 6, 2007
CD34(+) progenitors are reproducibly recovered in thawed umbilical grafts, and positively influence haematopoietic reconstitution after transplantation
C Lemarie, B Esterni, B Calmels, et al.
Cytotherapy
|
June 5, 2002
CD34(+) immunoselected cells for poor graft function following allogeneic BMT
M Mohty, C Faucher, C Chabannon, et al.
Bone Marrow Transplantation
|
February 26, 2008
Reduced-intensity conditioning allogeneic SCT as salvage treatment for relapsed multiple myeloma
H de Lavallade, J El-Cheikh, C Faucher, et al.
Bone Marrow Transplantation
|
August 26, 1998
Clinical and economic comparison of lenograstim-primed blood cells (BC) and bone marrow (BM) allogeneic transplantation
C Faucher, C Fortanier, P Viens, et al.
Page
of 14